insights_auto
Why is MESO up 2.42%?
Dive Deeperchevron_right
MESO:NASDAQ
Mesoblast Ltd
$13.94
arrow_upward
+2.42%(+0.33) 1D
$13.95
arrow_upward
+0.07% (+0.010)bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
$13.71
High
$14.10
Low
$13.71
Mkt. cap
1.83B
Avg. vol.
216.22K
Volume
241.93K
52-wk high
$21.49
52-wk low
$13.05
EPS
-$0.44
Beta
2.14
Shares outstanding
129.87M
No. of employees
108
Open
$13.71
High
$14.10
Low
$13.71
Mkt. cap
1.83B
Avg. vol.
216.22K
Volume
241.93K
52-wk high
$21.49
52-wk low
$13.05
EPS
-$0.44
Beta
2.14
Shares outstanding
129.87M
No. of employees
108
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Mesoblast wins FDA assay approval: what it means for Mesoblast stock
AD HOC NEWS
·
1 day ago
Mesoblast stock fell 4.29 percent as Ryoncil controls advanced
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd